An investor's guide to the sector and its regulations.
Our health advisory practice encompasses proactive risk management and strategic advice prior to undertaking a project or health program, a critical response service following a serious incident including risk management and brand protection, regulatory and compliance advice, safety and quality initiatives, system reviews, corporate and clinical governance obligations including arising from health reforms, drafting facility by-laws with associated credentialing reviews, e-health implementation and privacy obligations.
Our lawyers apply their in-depth understanding of the health sector, their clients operations, and the regulatory environment to provide practical advice and transaction support.
On 31 December 2012, the China International Economic and Trade Arbitration Commission (CIETAC), a foreign-related arbitration commission set up by the China Council for the Promotion of International Trade (also known as the China Chamber of International Commerce) (CCPIT), released its Announcement on Issues Concerning CIETAC Shanghai Sub-Commission and CIETAC South China Sub-Commission" (the Latest Announcement). This is the latest development in a dispute, which has been on foot since April 2012, between CIETAC, the Shanghai Sub-Commission of CIETAC (CIETAC Shanghai), and the Shenzhen Court of International Arbitration (SCIA) (the CIETAC Dispute). SCIA was known as the South China Sub-Commission of CIETAC before 22 October 2012.
On Tuesday, 29 November 2011, as part of its Mid-Year Economic and Fiscal Outlook 2011-12, the Federal Government announced a package of changes intended to raise A$11.5 billion in new revenue and savings.